US Guidelines For Psychiatric Care, And Drugs Use

12 December 1994

The American Psychiatric Association has issued the first guidelines to help psychiatrists with manic-depressive patients. It took two years to develop the guidelines, which call for long-term psychiatric care and use of some drugs.

While the guidelines state that there is no cure for the disease, the APA noted that up to 80% of patients with the illness will see significant improvement with appropriate treatment. Among the APA's recommendations are that:

- lithium helps 80% of patients by preventing manic-depressive episodes and calming mood instability;

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight